What is Inhibrx Biosciences, Inc. Common Stock's Market Cap?

Inhibrx Biosciences, Inc. Common Stock's Market Cap is $1.7B, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's Enterprise Value?

Inhibrx Biosciences, Inc. Common Stock's Enterprise Value is $1.7B, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's EV / EBITDA?

Inhibrx Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's Revenue (TTM)?

Inhibrx Biosciences, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's Net Income (TTM)?

Inhibrx Biosciences, Inc. Common Stock's Net Income (TTM) is -$138.2M, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's EBITDA?

Inhibrx Biosciences, Inc. Common Stock's EBITDA is -$125.6M, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's Diluted EPS (TTM)?

Inhibrx Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -9.39, based on as-reported figures from SEC (XBRL) filings.

What is Inhibrx Biosciences, Inc. Common Stock's Net Debt?

Inhibrx Biosciences, Inc. Common Stock's Net Debt is $42.9M, based on as-reported figures from SEC (XBRL) filings.

Inhibrx Biosciences, Inc. Common Stock (INBX) Financial Statements

Inhibrx Biosciences, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00P80N9V6

XNAS · usd

114.34▼ 6.83 (-5.64%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close121.17

Day's Range94.00 – 120.18

52-Week Range26.19 – 155.00

Volume1.6M

Avg Volume294.4K

Share Statistics

Shares Outstanding

Employees110

ExchangeXNAS

Listed2024-05-28

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Inhibrx Biosciences, Inc. Common Stock (INBX)

What is Inhibrx Biosciences, Inc. Common Stock's Market Cap?: Inhibrx Biosciences, Inc. Common Stock's Market Cap is $1.7B, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's Enterprise Value?: Inhibrx Biosciences, Inc. Common Stock's Enterprise Value is $1.7B, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's EV / EBITDA?: Inhibrx Biosciences, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's Revenue (TTM)?: Inhibrx Biosciences, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's Net Income (TTM)?: Inhibrx Biosciences, Inc. Common Stock's Net Income (TTM) is -$138.2M, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's EBITDA?: Inhibrx Biosciences, Inc. Common Stock's EBITDA is -$125.6M, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's Diluted EPS (TTM)?: Inhibrx Biosciences, Inc. Common Stock's Diluted EPS (TTM) is -9.39, based on as-reported figures from SEC (XBRL) filings.
What is Inhibrx Biosciences, Inc. Common Stock's Net Debt?: Inhibrx Biosciences, Inc. Common Stock's Net Debt is $42.9M, based on as-reported figures from SEC (XBRL) filings.